Recruiting OBSERVATIONAL NCT07421739

Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

Sponsor: Aura Biosciences

Conditions Choroidal Melanoma Indeterminate Lesions Ocular Melanoma Uveal Melanoma

Interventions Non-interventional, digital, patient-reported, real-world study

Updated 1 time since 2026 Last updated: Feb 17, 2026 Started: Nov 12, 2025 Primary completion: Aug 15, 2028 Completion: Aug 15, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Choroidal Melanoma and Indeterminate Lesions and is currently actively recruiting participants. Aura Biosciences leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

1 version recorded

Recruiting [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aura Biosciences
Vitaccess Ltd

Data source: Aura Biosciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• East Melbourne, Australia